DASEKE INC (DSKE)

US23753F1075 - Common Stock

8.3  +0.01 (+0.12%)

After market: 8.3 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to DSKE. DSKE was compared to 37 industry peers in the Ground Transportation industry. DSKE has a bad profitability rating. Also its financial health evaluation is rather negative. DSKE has a expensive valuation and it also scores bad on growth.



3

1. Profitability

1.1 Basic Checks

DSKE had negative earnings in the past year.
In the past year DSKE had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: DSKE reported negative net income in multiple years.
Each year in the past 5 years DSKE had a positive operating cash flow.

1.2 Ratios

DSKE has a worse Return On Assets (-2.38%) than 77.78% of its industry peers.
The Return On Equity of DSKE (-17.83%) is worse than 77.78% of its industry peers.
DSKE has a worse Return On Invested Capital (3.56%) than 61.11% of its industry peers.
DSKE had an Average Return On Invested Capital over the past 3 years of 6.16%. This is in line with the industry average of 7.80%.
Industry RankSector Rank
ROA -2.38%
ROE -17.83%
ROIC 3.56%
ROA(3y)2.01%
ROA(5y)-4.28%
ROE(3y)11.4%
ROE(5y)-38.32%
ROIC(3y)6.16%
ROIC(5y)4.58%

1.3 Margins

Looking at the Operating Margin, with a value of 2.79%, DSKE is doing worse than 69.44% of the companies in the same industry.
DSKE's Operating Margin has improved in the last couple of years.
DSKE has a Gross Margin of 56.56%. This is in the better half of the industry: DSKE outperforms 63.89% of its industry peers.
In the last couple of years the Gross Margin of DSKE has remained more or less at the same level.
Industry RankSector Rank
OM 2.79%
PM (TTM) N/A
GM 56.56%
OM growth 3Y-8.74%
OM growth 5Y5.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.93%
GM growth 5Y0.72%

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so DSKE is destroying value.
The number of shares outstanding for DSKE has been increased compared to 1 year ago.
DSKE has less shares outstanding than it did 5 years ago.
DSKE has a worse debt/assets ratio than last year.

2.2 Solvency

DSKE has an Altman-Z score of 1.46. This is a bad value and indicates that DSKE is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.46, DSKE is doing worse than 66.67% of the companies in the same industry.
DSKE has a debt to FCF ratio of 7.40. This is a slightly negative value and a sign of low solvency as DSKE would need 7.40 years to pay back of all of its debts.
The Debt to FCF ratio of DSKE (7.40) is better than 72.22% of its industry peers.
DSKE has a Debt/Equity ratio of 3.72. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of DSKE (3.72) is worse than 86.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.72
Debt/FCF 7.4
Altman-Z 1.46
ROIC/WACC0.39
WACC9.09%

2.3 Liquidity

A Current Ratio of 1.12 indicates that DSKE should not have too much problems paying its short term obligations.
DSKE's Current ratio of 1.12 is in line compared to the rest of the industry. DSKE outperforms 47.22% of its industry peers.
DSKE has a Quick Ratio of 1.11. This is a normal value and indicates that DSKE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.11, DSKE is in line with its industry, outperforming 47.22% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 1.11

0

3. Growth

3.1 Past

The earnings per share for DSKE have decreased strongly by -177.63% in the last year.
DSKE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.50%.
DSKE shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.55% yearly.
EPS 1Y (TTM)-177.63%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-800%
Revenue 1Y (TTM)-11.5%
Revenue growth 3Y2.58%
Revenue growth 5Y-0.55%
Revenue growth Q2Q-11.81%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y125.93%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.36%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

3

4. Valuation

4.1 Price/Earnings Ratio

DSKE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 54.25 indicates a quite expensive valuation of DSKE.
69.44% of the companies in the same industry are cheaper than DSKE, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of DSKE to the average of the S&P500 Index (22.79), we can say DSKE is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 54.25

4.2 Price Multiples

DSKE's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. DSKE is cheaper than 77.78% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, DSKE is valued cheaply inside the industry as 97.22% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 4.43
EV/EBITDA 6.45

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for DSKE!.
Industry RankSector Rank
Dividend Yield N/A

DASEKE INC

NASDAQ:DSKE (3/28/2024, 4:14:41 PM)

After market: 8.3 0 (0%)

8.3

+0.01 (+0.12%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryGround Transportation
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap391.76M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 54.25
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.38%
ROE -17.83%
ROCE
ROIC
ROICexc
ROICexgc
OM 2.79%
PM (TTM) N/A
GM 56.56%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.38
Health
Industry RankSector Rank
Debt/Equity 3.72
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.12
Quick Ratio 1.11
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-177.63%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y125.93%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-11.5%
Revenue growth 3Y2.58%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y